Chemomab Therapeutics (CMMB) Profit After Tax (QoQ) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Chemomab Therapeutics | 959.23 Mn | 948.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.52% |
| Sep 30, 2025 | -15.31% |
| Jun 30, 2025 | -38.10% |
| Mar 31, 2025 | 12.15% |
| Dec 31, 2024 | -14.93% |
| Sep 30, 2024 | -4.08% |
| Jun 30, 2024 | -6.13% |
| Mar 31, 2024 | 108.59% |
| Dec 31, 2023 | -1,203.28% |
| Sep 30, 2023 | -48.80% |
| Jun 30, 2023 | -8.95% |
| Mar 31, 2023 | 205.81% |
| Dec 31, 2022 | -202.38% |
| Sep 30, 2022 | 30.53% |
| Jun 30, 2022 | 221.28% |
| Mar 31, 2022 | -1.35% |
| Dec 31, 2021 | -69.68% |
| Sep 30, 2021 | -7.15% |
| Jun 30, 2021 | -62.56% |
| Mar 31, 2021 | 12.66% |
| Dec 31, 2020 | -59.40% |
| Sep 30, 2020 | -13.23% |
| Jun 30, 2020 | 36.22% |
| Mar 31, 2020 | 69.75% |
| Dec 31, 2019 | 21.82% |
| Sep 30, 2019 | -61.48% |
| Jun 30, 2019 | 55.22% |
| Mar 31, 2019 | -647.98% |
| Dec 31, 2018 | -31.30% |
| Sep 30, 2018 | -50.30% |
| Jun 30, 2018 | 49.70% |
| Mar 31, 2018 | 81.67% |